detalle del documento
IDENTIFICACIÓN

oai:HAL:hal-04051040v1

Tema
Alzheimer's disease biomarker Electrochemical biosensor Molecularly imprinted polymer (MIP... Parkinson's disease biomarker [CHIM]Chemical Sciences
Autor
Pilvenyte, Greta Ratautaite, Vilma Boguzaite, Raimonda Samukaite-Bubniene, Urte Plausinaitis, Deivis Ramanaviciene, Almira Bechelany, Mikhael Ramanavicius, Arunas
Langue
en
Editor

HAL CCSD;Elsevier

Categoría

Chemical Sciences

Año

2023

fecha de cotización

7/12/2023

Palabras clave
alzheimer diseases biomarker parkinson molecularly imprinted polymers disease biomarkers
Métrico

Resumen

International audience; The appearance of the biomarkers in body fluids like blood, urine, saliva, tears, etc. can be used for the identification of many diseases.

This article aimed to summarize the studies about electrochemical biosensors with molecularly imprinted polymers as sensitive and selective layers on the electrode to detect protein-based biomarkers of such neurodegenerative diseases as Alzheimer's disease, Parkinson's disease, and stress.

The main attention in this article is focused on the detection methods of amyloid-β oligomers and p-Tau which are representative biomarkers for Alzheimer's disease, α-synuclein as the biomarker of Parkinson's disease, and α-amylase and lysozyme as the biomarkers of stress using molecular imprinting technology.

The research methods, the application of different electrodes, the influence of the polymers, and the established detection limits are reviewed and compared

Pilvenyte, Greta,Ratautaite, Vilma,Boguzaite, Raimonda,Samukaite-Bubniene, Urte,Plausinaitis, Deivis,Ramanaviciene, Almira,Bechelany, Mikhael,Ramanavicius, Arunas, 2023, Molecularly imprinted polymers for the recognition of biomarkers of certain neurodegenerative diseases, HAL CCSD;Elsevier

Documento

Abrir

Compartir

Fuente

Artículos recomendados por ES/IODE IA

High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation
bladder cancer pfk-1 zeb1 lactylation glycolysis inhibits lactate glucose bc pfk-1 cancer lactylation cells bladder